-
Featured Authors
Events
Category Archives: Events
Latest From Events
Award Honors Rhode Island Biotech Excellence
Know somebody in Rhode Island biotech that deserves special recognition? Then nominate them for Tech Collective’s Rhode Island Bioscience Awards. Check it out, nominate, and apply here. Nominations are due September 24th, Applications are due October 1st.
Jim Greenwood Shares his Thoughts on BIO India
As a non-profit trade association that represents the biotech industry, BIO is pleased to bring the BIO International Conference back to India in an effort to further create and drive business development and collaborations between the US and Indian industry in all areas relating to biotechnology. The conference, which will be held in Mumbai this year on September 12-13, brings together global business and thought leaders in the various areas of biotechnology for partnering. For Read More >
BioSpectrum Asia Survey Shows Promising Results for the Biosciences Industry
BioSpectrum Asia recently completed a survey of close to 500 bioscience companies listed on different stock exchanges in both the Asia Pacific region (APAC) and in American stock exchanges, with total revenue of $139 billion (year end 2011) and market capitalization of $200 billion. The survey says of the top 20 companies in the region, comprising mostly of pharmaceutical, biotechnology and medical technology companies and focusing on R&D, manufacturing and marketing of life sciences products, Read More >
2012 BIO Investor Forum: Looking Ahead to Investment Opportunities
The biggest biotech news out of Washington in recent months was the Jumpstart Our Business Startups (JOBS) Act, which passed Congress overwhelmingly and was signed into law by President Obama in April. For those not familiar, the JOBS Act creates a new category of issuers, called “emerging growth companies” (EGCs), which is defined as newly public companies with than $1 billion in annual revenues and a public float below $700 million. EGCs are given a Read More >
Spotlight on India’s Emerging Biotech Sector
India’s biotechnology sector is a burgeoning one, with more than 325 companies and some with revenues in the billions of dollars. According to the BioSpectrum-ABLE (Association of Biotechnology Led Enterprises) Biotech Industry Survey of 2011, the industry has grown by 21.5% in 2006-2011, surging to $4 billion. Furthermore, India is the world’s largest manufacturer of vaccines and the growth of India vaccine makers arises from their ability to develop and produce high-quality vaccines with low Read More >
